StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3029% above fair value
$515.02−5.64 (-1.08%)

Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –

Vertex Pharmaceuticals Retained earnings (accumulated deficit) by Quarter

Retained earnings (accumulated deficit) ($M) ($M)

Vertex Pharmaceuticals Retained earnings (accumulated deficit): $15,691M in Q2 2026, up 39.0% from a year earlier. That is the highest of the 67 quarters on record here.

Latest, Q2 2026
15,691
Period ended Jun 30, 2026
Change on a year earlier
+39.0%
11,286 in Q2 2025
History
67 quarters
Since Q4 2009
Sources
65
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K (DB).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRetained earnings (accumulated deficit) ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202615,691+39.0%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 202614,591+42.3%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 202513,560+41.2%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 202512,369+42.3%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 202511,286+47.6%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 31, 202510,253-8.8%Form 10-Q (filed 2025-05-06) ↗
Q4 2024Dec 31, 20249,607-5.3%Form 10-K (filed 2025-02-13) ↗
Q3 2024Sep 30, 20248,694-5.2%Form 10-Q (filed 2024-11-05) ↗
Q2 2024Jun 30, 20247,648-6.0%Form 10-Q (filed 2024-08-02) ↗
Q1 2024Mar 31, 202411,242+55.7%Form 10-Q (filed 2024-05-07) ↗
Q4 2023Dec 31, 202310,142+55.5%Form 10-K (filed 2024-02-15) ↗
Q3 2023Sep 30, 20239,174+60.8%Form 10-Q (filed 2023-11-07) ↗
Q2 2023Jun 30, 20238,138+70.5%Form 10-Q (filed 2023-08-02) ↗
Q1 2023Mar 31, 20237,223+82.3%Form 10-Q (filed 2023-05-02) ↗
Q4 2022Dec 31, 20226,523+103.8%Form 10-K (filed 2023-02-10) ↗
Q3 2022Sep 30, 20225,704+134.7%Form 10-Q (filed 2022-10-28) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Retained earnings (accumulated deficit) ($M), quarterly Q4 2009–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/fs-re

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?